Project Insulin is a brand that believes in the fundamental right to healthcare, recognizing the burden that high insulin prices place on patients. With a mission to alleviate this struggle, they specialize in creating and offering affordable insulin. Led by Eric Moyal, the Founder and Executive Director, Project Insulin is committed to making insulin more accessible to those in need.

Before starting this groundbreaking initiative, Eric Moyal was actively involved in fundraising at Brandeis University, where he played a key role in coordinating successful campaigns that raised over $2,000,000. He also serves on the Board of Directors and chairs the communications committee at the Reflex Sympathetic Dystrophy Syndrome Association. In addition to Eric, the team includes Gabriella Fleischman, a Board Member, and Ph.

D. Gabriella, who personally lives with type 1 diabetes, brings her expertise in health and development economics to advance equity and health behavior. Project Insulin is dedicated to transforming the insulin market and ensuring that affordable options are available to all, striving to make a positive impact on the lives of patients